Increased incidence of sterile endophthalmitis following intravitreal preserved triamcinolone acetonide

British Journal of Ophthalmology

Volumn 92, Issue 8, 2008, Pages 1051-1054

  Jonisch, J ^a   Lai, J C ^a,b,c   Deramo, V A ^a,b   Flug, A J ^a   Fastenberg, D M ^a,b  

^a North Shore Long Island Jewish Health System ^*  (United States)

^b Long Island and Queens Vitreo Retinal Consultants   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; CULTURE TECHNIQUE; DIABETIC MACULAR EDEMA; EYE INFLAMMATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; PSEUDOPHAKIA; RETINA VEIN OCCLUSION; STATISTICAL SIGNIFICANCE; STERILE ENDOPHTHALMITIS; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; ENDOPHTHALMITIS; GLUCOCORTICOIDS; HUMANS; INJECTIONS; MIDDLE AGED; PRESERVATIVES, PHARMACEUTICAL; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY; VITREOUS BODY;

EID: 49049092808     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2007.136069     Document Type: Article

References (25)

1. Greenberg PB, Martidis A, Rogers AH, et al. Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol 2002;86:247-8.
2. Martidis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002;109:920-7.
3. Jonas JB, Kreissig I, et al. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 2003;121:57-61.
4. Jonas JB, Sofker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 2001;132:425-7.
5. Antcliff RJ, Spalton DJ, Stanford MR, et al. Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology 2001;108:765-72.
6. Jonas JB, Kreissig I, Degenring RF. Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema. Am J Ophthalmol 2003;136:384-6.
7. Challa JK, Gillies MC, Penfold PL, et al. Exudative macular degeneration and intravitreal triamcinolone: 18-month follow-up. Aust N Z J Ophthalmol 1998; 26:277-81.
8. Danis RP, Ciulla TA, et al. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 2000;20:244-50.
9. Jonas JB, Kreissig I, Hugger P, et al. Intravitreal triamcinolone acetonide for exudative age related macular degeneration. Br J Ophthalmol 2003;87:462-8.
10. Spaide RF, Sorenson J, Maranan L. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization. Ophthalmology 2005;112:301-4.
11. Wingate RJ, Beaumont PE. Intravitreal triamcinolone and elevated intraocular pressure. Aust N Z J Ophthalmol 1999;27:431-2.
12. Bakri SJ, Beer PM. The effect of intravitreal triamcinolone acetonide on intraocular pressure. Ophthalmic Surg Lasers Imaging 2003;34:386-90.
13. Jonas JB, Kreissig I, Degenring R. Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol 2003;87:24-7.
14. Jager RD, Aiello LP, et al. Risks of intravitreous injection: a comprehensive review. Retina 2004;24:676-98.
15. Jonas JB, Kreissig I, Degenring RF. Endophthalmitis after intravitreal injection of triamcinolone acetonide. Arch Ophthalmol 2003;121:1663-4.
16. Moshfeghi DM, Kaiser PK, Scott IU, et al. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 2003;136:791-6.
17. Nelson ML, Tennant MT, Sivalingam A, et al. Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina 2003;23:686-91.
18. Westfall AC, Osborn A, Kuhl D, et al. Acute endophthalmitis incidence: intravitreal triamcinolone, Arch Ophthalmol 2005;123:1075-7.
19. Moshfeghi AA, Scott IU, et al. Pseudohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edema. Am J Ophthalmol 2004;138:489-92.
20. Sutler FK, Gillies MC. Pseudo-endophthalmitis after intravitreal injection of triamcinolone. Br J Ophthalmol 2003;87:972-4.
21. Roth DB, Chieh J, Spirn MJ, et al. Noninfectious endophthalmitis associated with intravitreal triamcinolone injection. Arch Ophthalmol 2003;121:1279-82.
22. Pearson FC, Dubczak J, Weary M, et al. Detection of endotoxin in the plasma of patients with Gram-negative bacterial sepsis by the Limulus amoebocyte lysate assay. J Clin Microbiol 1985;21:865-8.
23. Lorenzo CJ, González BM, Pérez FI. Sterile endophthalmitis after benzyl alcohol filtered triamcinolone acetonide injection. Arch Ophthalmol 2008;126:142-3.
24. Chang DC, Grant GB, O'Donnell K, et al. Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution. JAMA 2006;296:953-63.
25. Bhavsar AR, Ip MS, Glassman AR, DRCRnet and the SCORE Study Groups. The risk of endophthalmitis following intravitreal triamcinolone injection in the DRCRnet and SCORE clinical trials. Am J Ophthalmol 2007;144:454-6.